Concord Biotech

Quarterly
Consolidated
ParticularsSep '25Dec '25Mar '26Jun '26Sep '26
Revenue260.41287.75341.43270.32319.24
Expenses177.02197.61227.17193.25223.10
EBITDA101.84108.96133.8895.20114.55
EBIT85.7486.24114.1678.3895.51
Profit Before Tax85.6886.15114.0878.3595.48
Net Profit63.0663.6488.4757.7069.57
Financial Ratios
Operating Profit Margin42.15%37.79%41.00%37.47%36.85%
Net Profit Margin25.73%24.08%27.23%22.73%22.86%
Earning Per Share (Diluted)6.036.088.465.526.65
Dividends Per Share0.000.000.000.000.00